Abstract

A nitric oxide (•NO) spin-trapping technique combined with electron paramagnetic resonance (EPR) spectroscopy has been employed to measure the in vivo production of •NO in lipopolysaccharide (LPS)-treated mice. The in vivo spin-trapping of •NO was performed by injecting into mice a metal—chelator complex, consisting of N-methyl- d-glucamine dithiocarbamate (MGD) and reduced iron (Fe 2+), that binds to •NO and forms a stable, water-soluble [(MGD) 2-Fe 2+-NO] complex, and by monitoring continuously the in vivo formation of the latter complex using an S-band EPR spectrometer. At 6 h after intravenous injection of LPS, a three-line EPR spectrum of the [(MGD) 2-Fe 2+-NO] complex, was observed in the blood circulation of the mouse tail; the [(MGD) 2-Fe 2+] complex was injected subcutaneously 2 h before EPR measurement. No signal was detected in control groups. Administration of N G-monomethyl- l-arginine, an •NO synthase inhibitor, caused a marked reduction in the in vivo EPR signal of the [(MGD) 2-Fe 2+-NO] complex, suggesting that the •NO detected is synthesized via the arginine-nitric oxide synthase pathway. The results presented here demonstrated, for the first time, the in vivo real time measurement of •NO in the blood circulation of conscious, LPS-treated animals.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call